Strain-dependent differences in corticolimbic processing of aversive or rewarding stimuli by ANDOLINA, DIEGO et al.
SYSTEMS NEUROSCIENCE
MINI REVIEW ARTICLE
published: 04 February 2015
doi: 10.3389/fnsys.2014.00207
Strain-dependent differences in corticolimbic processing of
aversive or rewarding stimuli
Diego Andolina1,2*, Stefano Puglisi-Allegra2,3 and Rossella Ventura2,3
1 Dipartimento di Scienze Cliniche Applicate e Biotecnologie, Università degli Studi dell’Aquila, L’Aquila, Italy
2 Santa Lucia Foundation, Rome, Italy










Diego Andolina, Dipartimento di
Scienze Cliniche Applicate e
Biotecnologie, Università degli Studi




Aberrations in the elaboration of both aversive and rewarding stimuli characterize
several psychopathologies including anxiety, depression and addiction. Several studies
suggest that different neurotrasmitters, within the corticolimbic system, are critically
involved in the processing of positive and negative stimuli. Individual differences in
this system, depending on genotype, have been shown to act as a liability factor for
different psychopathologies. Inbred mouse strains are commonly used in preclinical
studies of normal and pathological behaviors. In particular, C57BL/6J (C57) and DBA/2J
(DBA) strains have permitted to disclose the impact of different genetic backgrounds
over the corticolimbic system functions. Here, we summarize the main findings
collected over the years in our laboratory, showing how the genetic background
plays a critical role in modulating amminergic and GABAergic neurotransmission in
prefrontal-accumbal-amygdala system response to different rewarding and aversive
experiences, as well as to stress response. Finally, we propose a top-down model for the
response to rewarding and aversive stimuli in which amminergic transmission in prefrontal
cortex (PFC) controls accumbal and amygdala neurotransmitter response.
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INTRODUCTION
Adaptive behavior involves the ability to represent the value of
positive or negative stimuli, establish predictions about them,
and use these predictions to guide behavior (O’Doherty, 2004).
Animals and humans have a propensity to seek out rewards, avoid
punishments, and cope with negative situations, such as stressful
events. Aberrations in the elaboration of aversive and rewarding
stimuli characterize several psychopathologies, including anxiety,
depression, and addiction. For instance, disorders of mood and
motivation are frequently associated with anhedonia (reduced
ability to experience pleasure), and alterations in neural process-
ing of rewarding and aversive stimuli have been recently proposed
as an endophenotype of depression (Hasler et al., 2004; McCabe
et al., 2009; Ventura et al., 2013). Thus, understanding the neural
mechanisms by which positive and aversive stimuli are elaborated
is critical for the development of therapeutic approaches for
several psychopathologies.
Mood and motivation disorders and other psychiatric con-
ditions have complicated etiologies and result from complex
interactions between genetic and environmental precipitating
factors. In psychobiology studies, inbred strains are a useful
tool to investigate the role of genetic factors, in interaction
with aversive and rewarding experiences, in susceptibility to
development and expression of psychopathology. In particular,
data from C57 and DBA have provided information on how
the response of specific neuronal systems is related to genetic
background.
THE USE OF THE INBRED STRAINS
The use of inbred strains of mice offers great advantages to studies
aimed to determine the function of neurotransmitter systems
with regard to the effects of psychotropic drugs, stressful events,
and various psychopathologies.
An inbred strain is a set of animals that is produced by at least
20 consecutive generations of sister-brother or parent-offspring
matings and that can be traced to a single ancestral pair in
the 20th or subsequent generations. Inbred animals are nearly
entirely homozygous, providing a well-defined and consistent
genotype for analysis. The genetic stability of inbred strains over
the years and through laboratories has allowed myriad relevant
information for several commonly used strains to be accumu-
lated. Thus, comparative studies on neurotransmitter activity in
various regions of the brain in inbred mouse strains, which have
differences of behavioral outcomes, is one approach to investi-
gate the neurochemical bases of behavioral expression. In any
experimental procedure that involves laboratory-bred stocks, the
results might reflect the strain and species that are used. There
is a significant amount of data on differences in the effects of
various experimental conditions against which the findings from
inbred strains can be referenced, controlling the influence of
this source of variability. Moreover, behavioral, pharmacologi-
cal, physiological, and biochemical comparisons between inbred
strains constitute a preliminary stage for more extensive genetic
research, such as quantitative trait loci (QTL) analysis, to identify
and map genes in mice. Such a strategy can facilitate extrapolation
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of the results to the human genome, due to the significant extent
of the linkage homology between human and mouse (Plomin
et al., 1991; Crabbe et al., 1994).
C57BL/6 AND DBA/2 STRAINS
C57BL/6 (C57) and DBA/2 (DBA) mice are among the most
frequently studied inbred strains with regard to psychobiology
because their behavioral responses have strain-dependent differ-
ences. Moreover, the functional and anatomical characteristics
of their brain neurotransmitter systems have been examined
extensively in these strains. A wealth of data on various param-
eters, such as neurotransmitter metabolism and release, receptor
density and distribution, and activity of second messengers, has
been accumulated. Consequently, data collected in these strains
can offer important indications about the relationship between
the behavioral and central effects of different neurotransmitters
and, more generally, the involvement of brain neurotransmitters
in the control of behavior.
Clinical and preclinical studies suggest that the prefrontal
cortex (PFC), striatum (including the nucleus accumbens (NAc))
and amygdala are activated by natural positive or negative salient
stimuli, constituting a common substrate for processing reward-
ing and aversive stimuli (Berridge and Robinson, 1998; Becerra
et al., 2001; Jensen et al., 2003; O’Doherty, 2004; Borsook et al.,
2007). Aminergic and amino acid transmission are the principal
modulatory mechanisms of the corticolimbic system, and the
dysregulation of these systems is linked to alterations in the
elaboration of aversive and rewarding stimuli underlying various
psychopathologies.
The main findings collected over the years in our lab, by
microdialysis experiments, have identified the role of several
prefrontal cortex-accumbal-amygdala neurotransmitter systems
in the elaboration of rewarding or aversive stimuli. Here we
report findings from two experimental paradigms: place condi-
tioning and forced swimming test (FST). The place condition-
ing paradigm permits to investigate the motivational salience
attribution process to conditioned stimuli that are associated
with primary rewarding and aversive events (Tzschentke, 1998;
Reynolds and Berridge, 2002). The FST is one of paradigms
most widely used to measure antidepressant activity of new
drugs. Moreover, FST allows to assess alterations in depression-
like behavior and coping response to stress in both normal and
genetically modified animals (Porsolt et al., 1977; Borsini and
Meli, 1988). The behavioral responses in the FST are thought to
engage a coping strategy (Thierry et al., 1984), in which immobil-
ity behavior is an index of higher perceived motivational impact
of a stressful experience. Finally, we used restraint stress to eval-
uate the time-dependent response induced by stress on different
neurotransmitters in specific brain areas by intracerebral in vivo
microdialysis.
BIOLOGICAL BASIS OF PROCESSING REWARDING/AVERSIVE
STIMULI: PREFRONTAL-AMYGDALA-ACCUMBAL SYSTEM
The NAc, together with the PFC and amygdala, can be considered
a component of the brain network that regulates effort-related
functions (Salamone and Correa, 2012). The prefrontal-accumbal
cathecolamine and system has been demonstrated to play a critical
role in processing both rewarding and aversive stimuli (Ventura
et al., 2007). Moreover, the amygdala is involved in Pavlovian
conditioning of emotional responses and modulates memory for
arousing experiences (Balleine, 2005; Balleine and Killcross, 2006;
McGaugh, 2006), and a complex anatomical and functional con-
nection between the amygdala, medial prefrontal cortex (mpFC),
and NAc has been reported (Del Arco and Mora, 2009 for review).
Studies showed a crucial role of mpFC/amygdala system in both
processing of rewarding and coping to aversive stimuli, including
stress conditions (Robinson and Berridge, 1993; Becerra et al.,
2001; Gottfried et al., 2002; Jensen et al., 2003; Borsook et al.,
2007; Andolina et al., 2013; Rudebeck et al., 2013). A growing
body of evidence indicates that the prefrontal aminergic system
controls both dopamine (DA) release in the NAc and GABA
release in the amygdala, sub-cortical areas that mediate the elabo-
ration of rewarding and aversive stimuli. Moreover, an alteration
of this process seems to characterize several psychopathologies,
including anxiety, depression, and addiction. Twin and adoption
studies have demonstrated a gene-environment interaction in
the development of psychiatric disorders, indicating that genetic
background modulates the capacity of an environmental risk
factor to give rise to mental illness (Caspi and Moffitt, 2006). In
preclinical studies, inbred strains are a useful tool to investigate
the role of genetic factors, in interaction with aversive and reward-
ing experiences, in susceptibility to development and expression
of psychopathology. Indeed, comparative study of brain neuro-
transmitter activity and behavior in different genetic backgrounds
is a major strategy for determining the neural basis of reward-
ing and aversive effects in relation to individual differences. In
particular, the C57 and DBA strains have allowed us to deter-
mine the impact of genetic background on corticolimbic system
function.
REWARDING STIMULI
The principal function of DA in motivational salience processes
and in the elaboration of rewarding stimuli has been widely
reported (Robinson and Berridge, 2001). Thus, increased DA
transmission in the NAc mediates the rewarding/reinforcing
effects of addictive drugs (Di Chiara and Imperato, 1988; Wise
and Rompre, 1989; Pontieri et al., 1995; Koob et al., 1998;
Robbins and Everitt, 1999; Ventura et al., 2003, 2005, 2007).
However, recent evidence suggests major involvement of brain
norepinephrine (NE) in the behavioral and central effects of
rewarding pharmacological and natural stimuli (Darracq et al.,
1998; Tassin, 1998; Drouin et al., 2001; Zarrindast et al., 2002;
Ventura et al., 2007; Latagliata et al., 2010; Puglisi-Allegra and
Ventura, 2012). Ventura et al. demonstrated that selective pre-
frontal NE depletion in mice abolished the increase of DA in
the NAc induced by various classes of drugs of abuse and food
(Ventura et al., 2003, 2005, 2007, 2008; Latagliata et al., 2010).
Moreover, these studies reported that an intact prefrontal cortical
NE is necessary for Conditioned Place Preference (CPP) induced
by amphetamine, morphine, cocaine, ethanol, and chocolate as
well as for reinstatement (relapse) of extinguished morphine-
induced CPP and for ethanol intake in a choice test (Ventura
et al., 2003, 2005, 2006, 2007; Latagliata et al., 2010). Thus,
they demonstrate that prefrontal NE transmission is crucial for
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accumbal DA release induced by pharmacological and natu-
ral rewarding stimuli and processing the rewarding/reinforcing
effects of these stimuli. Finally, in addition to the prefrontal
noradrenergic/accumbal dopaminergic neuronal circuit, differ-
ent studies showed a crucial role of mpFC/amygdala system in
processing of rewarding stimuli (Robinson and Berridge, 1993;
Becerra et al., 2001; Gottfried et al., 2002; Borsook et al., 2007;
Rudebeck et al., 2013).
Inter-individual differences have been frequently reported in
the elaboration of both rewarding and aversive stimuli. Genotype-
dependent control of corticolimbic neurotransmission could be
responsible for individual differences in the elaboration of pos-
itive and aversive stimuli and thus be linked to different sus-
ceptibility to psychopathologies. Our findings in C57 and DBA
mice support this hypothesis. Concerning the elaboration of
rewarding stimuli, we showed differential effects of drugs of abuse
(amphetamine), depending on genotype (Table 1). For instance,
mice of DBA background are hyporesponsive to the behavioral
effects of D-amphetamine, whereas C57 mice are highly respon-
sive to the stimulating/reinforcing effects of amphetamine, as
evidenced by increased locomotor activity, and amphetamine-
induced CPP (Zocchi et al., 1998; Cabib et al., 2000; Ventura
et al., 2004). Amphetamine produces lower prefrontal and higher
accumbal DA levels, as well as higher locomotor activity, in
C57 mice in comparison with DBA mice (Ventura et al., 2004).
Moreover, selective prefrontal DA depletion in DBA mice leads
to high DA outflow in the NAc and hyperlocomotion, com-
parable to those observed in C57 mice (Ventura et al., 2004).
This evidence demonstrates that mesocortical DA controls the
genotype-dependent effects of systemic amphetamine on mesoac-
cumbens DA release and locomotion. Nevertheless, as we have
stressed, noradrenergic transmission in the mpFC has significant
modulatory function on accumbal dopaminergic transmission
and mediates the rewarding/reinforcing effects of addictive drugs.
Because prefrontal DA inhibits NAc DA, whereas NE has been
suggested to be enabling (Darracq et al., 1998), we hypothesized
that an imbalance in NE/DA in the mpFC regulates DA in the NAc
and the related behavioral outcomes, rendering the C57 strain
more responsive than DBA. This hypothesis was confirmed by
experiments that demonstrated that selective prefrontal cortical
NE depletion abolishes the effects of amphetamine on DA in
the accumbens and CPP in C57 mice (Ventura et al., 2003),
whereas selective prefrontal DA depletion (sparing NE) leads to
DA outflow in the NAc and behavioral outcomes in DBA mice,
similar to those of C57 (Ventura et al., 2004, 2005). Thus, these
evidences demonstrated that genotype-dependent susceptibility
to the addictive properties of drugs of abuse (amphetamine)
involves imbalanced DA and NE transmission in the mesocorti-
colimbic system.
AVERSIVE STIMULI
Aversive pharmacological and natural experiences, such as
lithium and stress administration, have been shown to acti-
vate the same prefrontal cortical-subcortical network affected by
rewarding stimuli (Pascucci et al., 2007; Ventura et al., 2007,
2008). In fact, the authors observed that natural and pharma-
cological aversive stimuli induce a clear-cut increase of NE in
the mpFC and DA in the NAcs that was abolished by selective
prefrontal NE depletion (Ventura et al., 2007, 2008). Results
concerning natural, non-pharmacological aversive experiences
(restraint stress) have demonstrated the same prefrontal nora-
drenergic control on accumbal DA outflow in rats (Pascucci
et al., 2007). This study showed that exposure to a novel stressor
(restraint) promotes a rapid, massive, and transient increase
in NE release in the mpFC, paralleling the rise in mesoac-
cumbens DA release (Pascucci et al., 2007). Selective prefrontal
NE depletion prevents both the cortical NE response and the
increase in accumbens DA release, thus confirming the mod-
ulatory function of prefrontal NE transmission in accumbal
DA transmission induced also by aversive stimuli. All together,
these data demonstrate that catecholaminergic transmission in
the neural circuit comprising NAc and mpFC is crucial in both
stress response and processing of negative and positive stimuli
(Cabib et al., 1988; Le Moal and Simon, 1991; Pascucci et al.,
2007; Ventura et al., 2007, 2013; Cabib and Puglisi-Allegra,
2012).
In addition to the mpFC noradrenergic/accumbal dopamin-
ergic neuronal circuit, other brain areas and neurotransmitters,
such amygdala GABAergic transmission, are likely to be engaged
in these processes. Concerning the prefrontal-amygdala system,
we have recently showed that amygdalar GABA regulation by
prefrontal 5-HT is critical for processing stressful experiences and
for determining passive coping outcomes, as measured by FST
in mice (Andolina et al., 2013). We have demonstrated that a
stressful experience, such as restraint, increases 5-HT levels in
the mpFC and GABA levels in the amygdala and that selective
depletion of cortical 5-HT canceled out these stress-induced
responses, implicating prefrontal 5-HT in the control of GABAer-
gic transmission in the amygdala during stress exposure. Sus-
tained stress-induced 5-HT outflow in the mpFC and GABA out-
flow in the basolateral amygdala (BLA) lead to sustained immo-
bility. However, a disconnection between prefrontal 5-HT and
amygdalar (BLA) GABAergic transmission leads to low immo-
bility in the FST (Andolina et al., 2013). These results highlight
other critical neural mechanisms in the perceived motivational
impact of stressful experiences in which the prefrontal/amygdala
connectivity mediated by 5-HT and GABA transmission has a
significant function. Concerning data from inbred strains of mice,
our restraint and FST results in C57 and DBA mice showed a
genotype control of corticolimbic neurotransmission (Table 1).
We found that restraint stress inhibited mesoaccumbens DA
release, which was accompanied by rapid and strong activation
of mesocortical DA metabolism in C57 mice; the opposite pat-
tern occurred in DBA mice, thus demonstrating genetic control
over the balance between mesocortical and mesoaccumbens DA
responses to stress (Ventura et al., 2001). Moreover, C57 but not
DBA mice experienced high immobility in their first session of
the FST and immediate and robust activation of mesocortical DA
metabolism and inhibition of mesoaccumbens DA metabolism
and release. In addition, the behavioral and mesoaccumbens
DA responses to FST in C57 mice were reduced and reversed,
respectively, by selective dopamine DA depletion in the mpFC
(Ventura et al., 2002). These studies showed that, as with reward-
ing stimuli, the genetic background governs the susceptibility
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Table 1 | Summary of behavioral response and neurotrasmitter release to rewarding and aversive stimuli shown by C57 and DBA mice.
Rewarding stimuli (amphetamine) References
Behavior Neurotrasmitter release
CPP Loc Act mpFC NAc
C57 ↑ Cabib et al. (2000)
DBA ↓ Ventura et al. (2003)
C57 ↑ DA ↓ DA ↑ Ventura et al. (2003, 2004)
DBA ↓ DA ↑ DA ↓ Zocchi et al. (1998)
Aversive stimuli (Stress)
Behavior Neurotrasmitter release
Immobility (FST) mpFC NAc Amy
C57 ↑ 5-HT ↑ (restraint) GABA ↑ (restraint) Andolina et al. (in press)
DBA ↓ 5-HT ↓ (restraint) GABA ↓ (restraint)
C57 ↑ DA ↑ (FST/restraint) DA ↓ (FST/restraint) Ventura et al. (2001, 2002)
DBA ↓ DA ↓ (FST/restraint) DA ↑ (FST/restraint)
↑ increase or ↓ decrease in comparison with DBA. Abbrevation: CPP, Conditioned Place Preference; Loc Act, Locomotor activity; FST, Forced
swimming test; mpFC, medial prefrontal cortex; NAc, nucleus accumbens; Amy, Amygdala; DA, Dopamine; 5-HT, Serotonin.
to stressful experiences through the mesocortical-limbic DA
response.
Another important neural network mediating stress responses
is the mpFC-amygdala circuit that has been shown to be
influenced by genotype (Holmes, 2008 for review). Specifically,
consistent with the evidence that we have discussed, C57 mice
have been reported to display greater immobility in the FST
compared to DBA mice (Alcaro et al., 2002; Ventura et al.,
2002). DBA and C57 mice are characterized by a different pre-
frontal 5-HT (Calcagno et al., 2007; Andolina et al., in press).
In particular, DBA mice present lower 5-HT transporter binding
and lower immobility in the FST than C57 (Sugimoto et al.,
2008; Popova et al., 2009). Moreover, DBA mice are homozy-
gous for the 1473G allele TPH-2, linked to low 5-HT synthesis
rate, while C57BL/6 mice are homozygous for the 1473C allele.
This allelic variant in DBA causes lower brain 5-HT synthesis
than in C57BL/6 mice carrying the “C” allele (Zhang et al.,
2004; Cervo et al., 2005). Moreover, differences between C57
and DBA mice have been reported for amygdala functioning
which have been linked to strain-dependent difference in stress
responsiveness (DuBois et al., 2006; Yang et al., 2008; Mozhui
et al., 2010). Consistent with the evidences that genetic varia-
tion in cortico-amygdala system contributes to individual differ-
ences in stress response and to stress-related behavior, recently
we reported that C57 mice show higher 5-HT outflow in the
mpFC and higher GABA outflow in the BLA induced by stress
(restraint) compared with the DBA strain. (Andolina et al., in
press).
All together, these data indicate that strain-dependent
prefrontal corticolimbic regulation, probably through different
neurotransmitter systems including NE, DA, 5-HT, and GABA
determines the differences in stress-coping behaviors in the FST
in C57 and DBA mice.
CONCLUSION
The evidences that we have discussed demonstrate that neuro-
transmission in the neural circuit comprising PFC, NAcs, and
amygdala, is crucial for processing rewarding and aversive stimuli.
Moreover, data on C57 and DBA strains demonstrate how the
genetic background determines the intensity and effects of the
response to positive and negative stimuli. Most of the experiments
that we have discussed above describe how selective NE, DA, or 5-
HT depletion in mpFC modifies the neurotransmitter response of
subcortical structures, such as the NAc and amygdala. PFC sends
glutamatergic outputs to subcortical areas, including the NAc and
amygdala, that mediate motor, emotional, and mnemonic func-
tion. In a top-down model, alterations in PFC neurotransmission
could modify the function of specific PFC cellular networks (Yang
and Chen, 2005; Del Arco and Mora, 2009) and, consequently, the
function of subcortical structures, including the NAc and amyg-
dala. This could lead to the development of abnormal behaviors
associated with psychiatric disorders, such as depression, anxiety,
and addiction. Our data support this model, wherein the amin-
ergic system in the mpFC has a central role in dopaminergic and
GABAergic neurotransmission in the NAc and amygdala, respec-
tively. Furthermore, our findings support a model of genotype-
dependent control of the prefrontal-accumbal-amygdala neural
circuit, which could mediate the differential behavioral responses
to many natural and pharmacological rewarding and aversive
stimuli.
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